Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.18 - $0.48 $139,009 - $370,692
-772,277 Reduced 47.99%
837,022 $251,000
Q1 2023

May 15, 2023

BUY
$0.34 - $1.19 $13,298 - $46,544
39,113 Added 2.49%
1,609,299 $691,000
Q4 2022

Feb 13, 2023

BUY
$1.03 - $2.0 $353,523 - $686,454
343,227 Added 27.97%
1,570,186 $1.85 Million
Q3 2022

Nov 14, 2022

BUY
$0.42 - $3.92 $226,185 - $2.11 Million
538,538 Added 78.23%
1,226,959 $2.85 Million
Q2 2022

Aug 12, 2022

BUY
N/A
111,506 Added 19.33%
688,421 $1.52 Million
Q1 2022

May 13, 2022

BUY
N/A
576,915 New
576,915 $5.56 Million

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0

About GreenLight Biosciences Holdings, PBC


  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.